Verdict Medical Devices

BofA projects positive Q3 FY 2025 for Medtronic, maintains stock Buy rating

Bank of America (BofA) forecasts that Medtronic will best its topline organic revenue growth expectations of 4.75% ahead of the medtech giant’s Q3 FY25 earnings call on 18 February. The post BofA projects positive Q3 FY 2025 for Medtronic, maintains stock Buy rating appeared first on Medical Device Network.

Feb 12, 2025 - 14:02
 0
BofA projects positive Q3 FY 2025 for Medtronic, maintains stock Buy rating
Bank of America (BofA) forecasts that Medtronic will best its topline organic revenue growth expectations of 4.75% ahead of the medtech giant’s Q3 FY25 earnings call on 18 February.

The post BofA projects positive Q3 FY 2025 for Medtronic, maintains stock Buy rating appeared first on Medical Device Network.

Read More

Tags:

Previous Article

Amid takeover talk, SpringWorks scores FDA nod for rare genetic disease treatmen...

Next Article

OZBE Café by KKOL Studio

Related Posts

Wearable defib maker Kestra targets $154m IPO

Wearable defib maker Kestra targets $154m IPO

Feb 27, 2025  0

EDX Medical develops new ‘super test’ for prostate cancer

EDX Medical develops new ‘super test’ for prostate cancer

Feb 17, 2025  0

GE HealthCare delivers first PET MPI agent doses for CAD detection

GE HealthCare delivers first PET MPI agent doses for CA...

Feb 26, 2025  0